A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

NCT03468855 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aclaris Therapeutics, Inc.